141 related articles for article (PubMed ID: 19825945)
1. Interferon-gamma-dependent infiltration of human T cells into neuroblastoma tumors in vivo.
Reid GS; Shan X; Coughlin CM; Lassoued W; Pawel BR; Wexler LH; Thiele CJ; Tsokos M; Pinkus JL; Pinkus GS; Grupp SA; Vonderheide RH
Clin Cancer Res; 2009 Nov; 15(21):6602-8. PubMed ID: 19825945
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of the antitumor activity of human Vγ9Vδ2 T cells in combination with zoledronic acid in a preclinical model of neuroblastoma.
Di Carlo E; Bocca P; Emionite L; Cilli M; Cipollone G; Morandi F; Raffaghello L; Pistoia V; Prigione I
Mol Ther; 2013 May; 21(5):1034-43. PubMed ID: 23481325
[TBL] [Abstract][Full Text] [Related]
3. Augmenting major histocompatibility complex class I expression by murine tumors in vivo enhances antitumor immunity induced by an active immunotherapy strategy.
Merritt RE; Yamada RE; Crystal RG; Korst RJ
J Thorac Cardiovasc Surg; 2004 Feb; 127(2):355-64. PubMed ID: 14762342
[TBL] [Abstract][Full Text] [Related]
4. IRF1 and NF-kB restore MHC class I-restricted tumor antigen processing and presentation to cytotoxic T cells in aggressive neuroblastoma.
Lorenzi S; Forloni M; Cifaldi L; Antonucci C; Citti A; Boldrini R; Pezzullo M; Castellano A; Russo V; van der Bruggen P; Giacomini P; Locatelli F; Fruci D
PLoS One; 2012; 7(10):e46928. PubMed ID: 23071666
[TBL] [Abstract][Full Text] [Related]
5. Persistent measles virus infection enhances major histocompatibility complex class I expression and immunogenicity of murine neuroblastoma cells.
Gopas J; Itzhaky D; Segev Y; Salzberg S; Trink B; Isakov N; Rager-Zisman B
Cancer Immunol Immunother; 1992; 34(5):313-20. PubMed ID: 1347254
[TBL] [Abstract][Full Text] [Related]
6. A novel anti-GD2/4-1BB chimeric antigen receptor triggers neuroblastoma cell killing.
Prapa M; Caldrer S; Spano C; Bestagno M; Golinelli G; Grisendi G; Petrachi T; Conte P; Horwitz EM; Campana D; Paolucci P; Dominici M
Oncotarget; 2015 Sep; 6(28):24884-94. PubMed ID: 26298772
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of class I major histocompatibility complex antigens by interferon gamma is necessary for T-cell-mediated elimination of recombinant adenovirus-infected hepatocytes in vivo.
Yang Y; Xiang Z; Ertl HC; Wilson JM
Proc Natl Acad Sci U S A; 1995 Aug; 92(16):7257-61. PubMed ID: 7638177
[TBL] [Abstract][Full Text] [Related]
8. Recognition of neuroectodermal tumors by melanoma-specific cytotoxic T lymphocytes: evidence for antigen sharing by tumors derived from the neural crest.
Shamamian P; Mancini M; Kawakami Y; Restifo NP; Rosenberg SA; Topalian SL
Cancer Immunol Immunother; 1994 Aug; 39(2):73-83. PubMed ID: 7519127
[TBL] [Abstract][Full Text] [Related]
9. Enhancing CTL responses to melanoma cell vaccines in vivo: synergistic increases obtained using IFNgamma primed and IFNbeta treated B7-1+ B16-F10 melanoma cells.
Dezfouli S; Hatzinisiriou I; Ralph SJ
Immunol Cell Biol; 2003 Dec; 81(6):459-71. PubMed ID: 14636243
[TBL] [Abstract][Full Text] [Related]
10. IL-27 mediates complete regression of orthotopic primary and metastatic murine neuroblastoma tumors: role for CD8+ T cells.
Salcedo R; Stauffer JK; Lincoln E; Back TC; Hixon JA; Hahn C; Shafer-Weaver K; Malyguine A; Kastelein R; Wigginton JM
J Immunol; 2004 Dec; 173(12):7170-82. PubMed ID: 15585838
[TBL] [Abstract][Full Text] [Related]
11. Reduction of MHC-I expression limits T-lymphocyte-mediated killing of Cancer-initiating cells.
Morrison BJ; Steel JC; Morris JC
BMC Cancer; 2018 Apr; 18(1):469. PubMed ID: 29699516
[TBL] [Abstract][Full Text] [Related]
12. Effects of murine tumor class I major histocompatibility complex expression on antitumor activity of tumor-infiltrating lymphocytes.
Weber JS; Rosenberg SA
J Natl Cancer Inst; 1990 May; 82(9):755-61. PubMed ID: 2109092
[TBL] [Abstract][Full Text] [Related]
13. Retinoids act as multistep modulators of the major histocompatibility class I presentation pathway and sensitize neuroblastomas to cytotoxic lymphocytes.
Vertuani S; De Geer A; Levitsky V; Kogner P; Kiessling R; Levitskaya J
Cancer Res; 2003 Nov; 63(22):8006-13. PubMed ID: 14633733
[TBL] [Abstract][Full Text] [Related]
14. Expression and modulation of major histocompatibility antigens on murine primary brain tumor in vitro.
Akbasak A; Oldfield EH; Saris SC
J Neurosurg; 1991 Dec; 75(6):922-9. PubMed ID: 1941122
[TBL] [Abstract][Full Text] [Related]
15. Radiation-induced IFN-gamma production within the tumor microenvironment influences antitumor immunity.
Lugade AA; Sorensen EW; Gerber SA; Moran JP; Frelinger JG; Lord EM
J Immunol; 2008 Mar; 180(5):3132-9. PubMed ID: 18292536
[TBL] [Abstract][Full Text] [Related]
16. Immunodeficient mouse strains display marked variability in growth of human melanoma lung metastases.
Carreno BM; Garbow JR; Kolar GR; Jackson EN; Engelbach JA; Becker-Hapak M; Carayannopoulos LN; Piwnica-Worms D; Linette GP
Clin Cancer Res; 2009 May; 15(10):3277-86. PubMed ID: 19447870
[TBL] [Abstract][Full Text] [Related]
17. Systemic Interferon-γ Increases MHC Class I Expression and T-cell Infiltration in Cold Tumors: Results of a Phase 0 Clinical Trial.
Zhang S; Kohli K; Black RG; Yao L; Spadinger SM; He Q; Pillarisetty VG; Cranmer LD; Van Tine BA; Yee C; Pierce RH; Riddell SR; Jones RL; Pollack SM
Cancer Immunol Res; 2019 Aug; 7(8):1237-1243. PubMed ID: 31171504
[TBL] [Abstract][Full Text] [Related]
18. Curative antitumor immune response is optimal with tumor irradiation followed by genetic induction of major histocompatibility complex class I and class II molecules and suppression of Ii protein.
Wang Y; Xu M; Che M; Von Hofe E; Abbas A; Kallinteris NL; Lu X; Liss ZJ; Forman JD; Hillman GG
Hum Gene Ther; 2005 Feb; 16(2):187-99. PubMed ID: 15761259
[TBL] [Abstract][Full Text] [Related]
19. Exogenous expression of mouse interferon gamma cDNA in mouse neuroblastoma C1300 cells results in reduced tumorigenicity by augmented anti-tumor immunity.
Watanabe Y; Kuribayashi K; Miyatake S; Nishihara K; Nakayama E; Taniyama T; Sakata T
Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9456-60. PubMed ID: 2512580
[TBL] [Abstract][Full Text] [Related]
20. Enhanced cell-mediated cytotoxicity by interferon-gamma and interleukin-2 against syngeneic murine mammary adenocarcinoma.
Nakajima I; Chu TM
Mol Biother; 1992 Mar; 4(1):47-52. PubMed ID: 1627274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
